Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life for heart failure patients, and may be a suitable option for patients with functional and secondary mitral regurgitation. In this touchCARDIO interview, we speak with Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) to discuss the benefits of using TEER compared to other approaches for treating functional mitral regurgitation in heart failure patients.
The abstract entitled ‘Transcatheter Edge-to-edge Repair Of Functional Mitral Regurgitation In Heart Failure: Final Five-year Results From The COAPT Trial‘ (Abstract number 405-12) was presented at ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, 4–6 March 2023.
Watch: Dr Gregg Stone discusses final five-year results from the COAPT Trial
Questions:
- What are some of the benefits of using transcatheter edge-to-edge repair compared to other approaches for treating functional mitral regurgitation in heart failure patients? (0:15)
Disclosures: Gregg Stone has received grant/research support from Abbott, and honoraria/honorarium from Abbott.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of ACC 2023
Access more content on heart failure and interventional cardiology
